Figure 2.

Three different intervals of H19 expression accordingly with three classes of cancer degeneration. H19 fold change expression levels in benign biopsies were the lowest (7.6 ± 2.85) followed by atypia and in situ lesions H19 fold change levels, while malignant lesions showed the highest H19 fold change expression (12.3 ± 5.5). Expression levels were normalized to GAPDH expression. Results were expressed as means ± SEM. ANOVA and t-test, *p < 0.05, **p < 0.01, ns p > 0.5.